Earnings Summary

Provention Bio Inc’s revenue jumped 1593.03% since last year same period to $12.14Mn in the Q4 2022. On a quarterly growth basis, Provention Bio Inc has generated 1505.69% jump in its revenue since last 3-months.

Provention Bio Inc’s net profit fell -228.84% since last year same period to $-84.93Mn in the Q4 2022. On a quarterly growth basis, Provention Bio Inc has generated -196.62% fall in its net profits since last 3-months.

Provention Bio Inc’s net profit margin jumped 80.58% since last year same period to -699.66% in the Q4 2022. On a quarterly growth basis, Provention Bio Inc has generated 81.53% jump in its net profit margins since last 3-months.

Provention Bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.55 - a -30.95% fall from last quarter’s estimates.

Provention Bio Inc’s earning per share (EPS) estimates for the current year stand at -0.55.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Provention Bio Inc’s return on assets (ROA) stands at -0.43.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Provention Bio Inc’s return on equity (ROE) stands at -0.98.